Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Journal of Clinical Psychopharmacology
|
January 2, 2013
Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
Claudia Schilling, Maria Gilles, Werner F Blum, et al.
Psychiatry Research. Neuroimaging
|
May 30, 2025
EEG vigilance and response to oral prolonged-release ketamine in treatment-resistant depression - A double-blind randomized validation study
Anna Monn, Corinne Eicher, Annia Rüesch, et al.
Journal of Affective Disorders
|
April 19, 2026
Neural signatures of major depression across the episodic memory circuitry
Cristina Ramponi, Lucien Gyger, Kevin Swierkosz-Lenart, et al.
Journal of Attention Disorders
|
July 27, 2017
Effectiveness of Psychotherapy in Adult ADHD: What Do Patients Think? Results of the COMPAS Study
Vivien Groß, Caroline Lücke, Erika Graf, et al.
Journal of Attention Disorders
|
March 24, 2012
German validation of the conners adult ADHD rating scale-self-report: confirmation of factor structure in a large sample of participants with ADHD
Hanna Christiansen, Oliver Hirsch, Alexandra Philipsen, et al.
Pharmacopsychiatry
|
October 5, 2020
Safety Profile of Methylphenidate Under Long-Term Treatment in Adult ADHD Patients - Results of the COMPAS Study
Bernhard Kis, Caroline Lücke, Mona Abdel-Hamid, et al.
BMC Psychiatry
|
May 9, 2025
Subgrouping suicidal ideations: an ecological momentary assessment study in psychiatric inpatients
Stephanie Homan, Zachary Roman, Anja Ries, et al.
JAMA Network Open
|
June 1, 2019
Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial
Alexandra P Lam, Swantje Matthies, Erika Graf, et al.
Annals of General Psychiatry
|
October 1, 2020
Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel
Andrea Fagiolini, José Ángel Alcalá, Thomas Aubel, et al.
Journal of Psychiatric Research
|
May 2, 2022
Multimodal treatment efficacy differs in dependence of core symptom profiles in adult Attention-Deficit/Hyperactivity Disorder: An analysis of the randomized controlled COMPAS trial
Benjamin Selaskowski, Christian Staerk, Niclas Braun, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Journal of Clinical Psychopharmacology
|
January 2, 2013
Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
Claudia Schilling, Maria Gilles, Werner F Blum, et al.
Psychiatry Research. Neuroimaging
|
May 30, 2025
EEG vigilance and response to oral prolonged-release ketamine in treatment-resistant depression - A double-blind randomized validation study
Anna Monn, Corinne Eicher, Annia Rüesch, et al.
Journal of Affective Disorders
|
April 19, 2026
Neural signatures of major depression across the episodic memory circuitry
Cristina Ramponi, Lucien Gyger, Kevin Swierkosz-Lenart, et al.
Journal of Attention Disorders
|
July 27, 2017
Effectiveness of Psychotherapy in Adult ADHD: What Do Patients Think? Results of the COMPAS Study
Vivien Groß, Caroline Lücke, Erika Graf, et al.
Journal of Attention Disorders
|
March 24, 2012
German validation of the conners adult ADHD rating scale-self-report: confirmation of factor structure in a large sample of participants with ADHD
Hanna Christiansen, Oliver Hirsch, Alexandra Philipsen, et al.
Pharmacopsychiatry
|
October 5, 2020
Safety Profile of Methylphenidate Under Long-Term Treatment in Adult ADHD Patients - Results of the COMPAS Study
Bernhard Kis, Caroline Lücke, Mona Abdel-Hamid, et al.
BMC Psychiatry
|
May 9, 2025
Subgrouping suicidal ideations: an ecological momentary assessment study in psychiatric inpatients
Stephanie Homan, Zachary Roman, Anja Ries, et al.
JAMA Network Open
|
June 1, 2019
Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial
Alexandra P Lam, Swantje Matthies, Erika Graf, et al.
Annals of General Psychiatry
|
October 1, 2020
Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel
Andrea Fagiolini, José Ángel Alcalá, Thomas Aubel, et al.
Journal of Psychiatric Research
|
May 2, 2022
Multimodal treatment efficacy differs in dependence of core symptom profiles in adult Attention-Deficit/Hyperactivity Disorder: An analysis of the randomized controlled COMPAS trial
Benjamin Selaskowski, Christian Staerk, Niclas Braun, et al.
Page
of 6